Call us today: +44 (0) 20 3551 6634
Expatriates may soon be able to use international healthcare insurance policies to fund a cure for a range of nervous system diseases, following a scientific breakthrough.
A research group, which was led by University of Central Florida bioengineer James Hickman and had its findings published in the journal ACS Chemical Neuroscience, converted stem cells from umbilical cords into other types of cells.
This could eventually result in people with conditions such as spinal cord injuries and multiple sclerosis having a new array of treatment options.
It is the first time this have ever happened without using embryonic stem cells, which overcomes many of the issues using this source can produce, Mr Hickman stated.
Umbilical cords would be discarded if they were not used, so they do not pose any ethical dilemmas.
Furthermore, their utility in medical procedures would be simplified as they have been found to typically not result in any immune reactions.
Postdoctoral researcher and lead author of the paper Hedvika Davis attempted to convert umbilical stem cells to critical parts of the human body called oligodendrocytes.
These insulate nerves in the spinal cord and brain and generally bind with norephinephrine, so she began to utilise this to stimulate them.
However, this procedure only resulted in a partial conversion, with the cells failing to reach a comparable level to that seen within the body.
Ms Davis then established a three-dimensional environment to reproduce the physical restrictions oligodendrocytes would typically face in humans, which was successful.
Injecting these into patients suffering from multiple sclerosis, diabetic neuropathy or related illnesses could result in their conditions improving, the researchers claimed.
It could also enable scientists to test potential treatments and understand what happens to these cells, they added.
"We want to use a model system to understand what's going on and also to look for possible therapies to repair some of the damage and we think there is great potential in both directions," Mr Hickman stated.
Stem cells could have potential for treating a wide range of other medical problems, including heart disease, burns, stroke, degenerative brain conditions and arthritis, as well as being utilised to test the efficacy of new drugs.
Expatriate Healthcare specialise in providing international health insurance. Make sure you're protected. © Expatriate Healthcare
Expatriate Group.Delmon House,36-38 Church Road,Burgess Hill,West Sussex,RH15 9AE
Registered Address.35 Ballards Lane,London,N3 1XW
Tel: +44 (0)20 3551 6634Fax: +44 (0)870 428 5141Email: firstname.lastname@example.org
Short Term Healthcare Insurance
Travel Medical Insurance One Way Travel Insurance Single Trip Travel Insurance Annual Multi-Trip Travel Insurance Non UK Resident Travel Insurance Business Travel Insurance
About Us Useful Links Leave a Review Our Awards The Press Room Satisfaction Survey Downloads Legal Notice Underwriters Hospital List
Emergency Assistance information Short-Term Healthcare Working Abroad Insurance Thailand Health Insurance Family & Friend Benefits
Register as an Intermediary Opportunities for Brokers
Expatriate Group & Expatriate Healthcare are trading styles of Strategic Insurance Services Limited who is authorised and regulated by the Financial Conduct Authority (FCA). FCA Firm reference Number is 307133. Strategic Insurance Services Limited is authorised to carry on Regulated Activities in accordance with the permissions granted by the FCA under PART IV of the Financial Services and Markets ACT 2000.